The Swiss Industrial Biocatalysis Consortium (SIBC) turns 20!

In 2024, the Swiss Industrial Biocatalysis Consortium (SIBC), celebrated its 20 years of bringing together experts from the pharma, flavor and fragrance, fine chemicals, and agrochemicals industries to discuss enzyme technology developments. In this perspective, we share recent examples of how our member organizations utilize biocatalysis in their respective industries. While the motivations for employing enzymatic synthesis and the end goals of various production processes may vary, we aim to emphasize the shared aspects that we are coming across. Over the past 20 years, those synergies have provided us with a fruitful basis for pre-competitive knowledge sharing around biocatalysis as a technology. We look forward to many more years of the SIBC and the surprises that await us through the potential of our enzymes.

Authors

Institutions

Publication Details

Journal
CHIMIA International Journal for Chemistry
Published
2025-05-27
DOI
https://doi.org/10.2533/chimia.2025.299
Primary Topic
Enzyme Catalysis and Immobilization
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Swiss Industrial Biocatalysis Consortium (SIBC) turns 20!

Eric Eichhorn, Elina Siirola, Steven P. Hanlon, Camille Le Chapelain et al.
CHIMIA International Journal for Chemistry
Enzyme Catalysis and Immobilization
article

The Swiss Industrial Biocatalysis Consortium (SIBC) turns 20!

Eric Eichhorn, Elina Siirola, Steven P. Hanlon, Camille Le Chapelain, Fabian Eggimann, Radka Šnajdrová, Kirsten Schroer, Katharina Neufeld, Hans Iding, Serena Bisagni, Alberto Kravina, Lukas Rigger
article en

Abstract

In 2024, the Swiss Industrial Biocatalysis Consortium (SIBC), celebrated its 20 years of bringing together experts from the pharma, flavor and fragrance, fine chemicals, and agrochemicals industries to discuss enzyme technology developments. In this perspective, we share recent examples of how our member organizations utilize biocatalysis in their respective industries. While the motivations for employing enzymatic synthesis and the end goals of various production processes may vary, we aim to emphasize the shared aspects that we are coming across. Over the past 20 years, those synergies have provided us with a fruitful basis for pre-competitive knowledge sharing around biocatalysis as a technology. We look forward to many more years of the SIBC and the surprises that await us through the potential of our enzymes.

CHIMIA International Journal for ChemistryVol. 79(5)
Roche (Switzerland) (CH), Novartis (Switzerland) (CH), Johnson & Johnson (United States) (US), Merck KGaA, Darmstadt (Germany) (DE), Givaudan (Switzerland) (CH), Syngenta (Switzerland) (CH), Lonza (Switzerland) (CH)
Industry, innovation and infrastructure
Openalex Percentile: Top 89%
Enzyme Catalysis and Immobilization
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.